Maxime (Max) de Brouwer is a seasoned financial executive with over 25 years of experience driving growth, financial transformation, and operational excellence in a variety of industries including biotech and life sciences. As SVP of Finance at Instil Bio, he built the finance function post-IPO, implementing SAP, SOX compliance, and strategic restructuring initiatives to redirect the company focus. Max played a pivotal role in cost reduction efforts to extend cash runway and financial strategy during the company’s evolution.

Previously, during his 14-year tenure at Grifols as divisional CFO, Max helped grow US revenue from $300M to $4.5B, spearheading M&A integrations, including the $4B Talecris Biotherapeutics acquisition. He led debt financing, financial operations, and strategic growth initiatives, helping Grifols become a global leader in plasma-derived therapies.

Max is currently doing consulting and is known for his expertise in M&A, financial turnarounds, and operational efficiency. He holds an MBA in Finance from UCLA’s Anderson School of Management and a Bachelor of Science in Accounting from USC. A CPA (inactive), Max brings a proven track record of scaling organizations, driving profitability, and optimizing financial performance in dynamic, high-growth environments. Max lives in La Canada and is the proud father of two daughters.